Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Jaeger

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Leukemia Research|March 6, 2012
The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practiceAntonio Salar, Corinne Haioun, Francesca G Rossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 22, 2011
Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphomaRuth Pettengell, Hans E Johnsen, Hans E Johnson, et al.
Hemasphere|August 28, 2024
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximabArnon P Kater, Barbara F Eichhorst, Carolyn J Owen, et al.
Blood|November 20, 2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsMichele Spina, Ulrich Jaeger, Joseph A Sparano, et al.
Cancers|November 27, 2021
Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell EraEdit Porpaczy, Philipp Wohlfarth, Oliver Königsbrügge, et al.
Blood|June 26, 2010
Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemiaMedhat Shehata, Susanne Schnabl, Dita Demirtas, et al.
European Journal of Clinical Investigation|June 20, 2014
Clofarabine/cyclophosphamide for debulking before stem cell transplantationWerner Rabitsch, Alexandra Böhm, Marija Bojic, et al.
International Journal of Cancer|February 7, 2022
The impact of COVID-19 on cancer care of outpatients with low socioeconomic statusElisabeth L Zeilinger, Simone Lubowitzki, Matthias Unseld, et al.
Psycho-Oncology|November 4, 2019
Screening for post-traumatic stress disorders in 1017 cancer patients and correlation with anxiety, depression, and distressMatthias Unseld, Katharina Krammer, Simone Lubowitzki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2018
Ultra-early response assessment in lymphoma treatment: [<sup>18</sup>F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatmentMarius E Mayerhoefer, Markus Raderer, Ulrich Jaeger, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Leukemia Research|March 6, 2012
The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practiceAntonio Salar, Corinne Haioun, Francesca G Rossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 22, 2011
Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphomaRuth Pettengell, Hans E Johnsen, Hans E Johnson, et al.
Hemasphere|August 28, 2024
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximabArnon P Kater, Barbara F Eichhorst, Carolyn J Owen, et al.
Blood|November 20, 2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsMichele Spina, Ulrich Jaeger, Joseph A Sparano, et al.
Cancers|November 27, 2021
Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell EraEdit Porpaczy, Philipp Wohlfarth, Oliver Königsbrügge, et al.
Blood|June 26, 2010
Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemiaMedhat Shehata, Susanne Schnabl, Dita Demirtas, et al.
European Journal of Clinical Investigation|June 20, 2014
Clofarabine/cyclophosphamide for debulking before stem cell transplantationWerner Rabitsch, Alexandra Böhm, Marija Bojic, et al.
International Journal of Cancer|February 7, 2022
The impact of COVID-19 on cancer care of outpatients with low socioeconomic statusElisabeth L Zeilinger, Simone Lubowitzki, Matthias Unseld, et al.
Psycho-Oncology|November 4, 2019
Screening for post-traumatic stress disorders in 1017 cancer patients and correlation with anxiety, depression, and distressMatthias Unseld, Katharina Krammer, Simone Lubowitzki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2018
Ultra-early response assessment in lymphoma treatment: [<sup>18</sup>F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatmentMarius E Mayerhoefer, Markus Raderer, Ulrich Jaeger, et al.
Pageof 11